Schizophrenia Home > Aripiprazole (Abilify)

The U.S. Food and Drug Administration (FDA) has licensed the drug aripiprazole (Abilify®) for the treatment of schizophrenia and bipolar disorder. When combined with antidepressants, it can be used to treat major depression. This medicine is believed to work by blocking or lessening the effects of certain chemicals in the brain, which makes it useful for such a wide range of conditions.
Aripiprazole is available in tablet and liquid forms, and also in a rapidly dissolving tablet (called Abilify Discmelt®) that does not need to be taken with water. The form your healthcare provider recommends will depend on various factors. Children, for example, may have an easier time with the liquid form.
(Click Aripiprazole for more information on this product, such as possible side effects, dosing guidelines, and what to do if you are pregnant or breastfeeding.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.